| Suzanna F Bailey, SLP | |
|
2506 Danville Rd Sw, Suite 200, Decatur, AL 35603-4232 | |
| (256) 350-6331 | |
| (256) 350-1990 |
| Full Name | Suzanna F Bailey |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2506 Danville Rd Sw, Decatur, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710137856 | NPI | - | NPPES |
| 529917620 | Medicaid | AL | |
| 1003819608 | Other | AL | NPI GROUP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP2349 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Suzanna F Bailey, SLP 1908 Flint Rd Se, Decatur, AL 35601-6031 Ph: (256) 340-9708 | Suzanna F Bailey, SLP 2506 Danville Rd Sw, Suite 200, Decatur, AL 35603-4232 Ph: (256) 350-6331 |
News Archive
The National Institutes of Health awarded six research grants for studies to develop a learning health care system for the treatment of early psychosis.
NABsys Inc., the pioneer in electronic, solid-state DNA sequencing, today announced that it has received a $7 million investment as part of a Series B equity round led by Stata Venture Partners. The funding will be used to accelerate the development and commercialization of the company's proprietary DNA sequencing platform, which leverages semiconductor technology to achieve the scope and scale required for full integration of genomics into medicine.
As medical marijuana states crack down on pesticides, molds and other adulterants in cannabis products, Neutra Corp. is helping to develop new technology to keep patients safe from potentially harmful contamination.
The drug Tysabri which was approved by the Food and Drug Administration (FDA) for the treatment of multiple sclerosis in November 2004, was taken off the market in late February, after two cases of progressive multifocal leukoencephalopathy, or PML, appeared in patients given the drug during clinical trials.
› Verified 7 days ago
Katelyn Meadows, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1350 14th Ave Se, Decatur, AL 35601 Phone: 256-355-6911 | |
Cristine K Pyle, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2506 Danville Rd Sw, Suite 200, Decatur, AL 35603 Phone: 256-350-6331 Fax: 256-350-1990 | |
Murphy Daily, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1350 14th Ave Se, Decatur, AL 35601 Phone: 256-355-6911 | |
Holley O'connell, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2411 Jarvis St Sw, Decatur, AL 35603 Phone: 205-965-9489 | |
Leslie Segars Barbee, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2506 Danville Rd Sw, Suite 200, Decatur, AL 35603 Phone: 256-350-6331 Fax: 256-350-1990 | |
Laura Batt, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2326 Morgan Ave Sw, Decatur, AL 35601 Phone: 256-739-1239 | |
Mrs. Katherine C Gaut-owens, M.S.,CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 922 6th Ave Se, Suite A, Decatur, AL 35601 Phone: 256-309-0454 Fax: 256-309-0422 |